Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the potential of using valsartan/HCTZ as initial
therapy in patients with severe hypertension compared to valsartan alone as initial therapy,
and to determine whether a greater proportion of patients achieve blood pressure control with
the combination compared to the monotherapy without producing an unacceptable adverse event
profile.